Funmilola Olaoye
Nurse Practitioner · Newark, DENPI 1548903610
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 334 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,874 and has fallen 70.5% since, to $848 in 2025. Among nurse practitioner clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 334 payments — averaging $22.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Abbott$784
- Cequr Corporation$649
- Corcept Therapeutics$455
- Lilly USA, LLC$450
- Amgen$441
- plus $3K from 29 others
What the payments were for
- Food & beverage$7,491100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 69 | $1,216 |
| Abbott | 43 | $784 |
| Cequr Corporation | 4 | $649 |
| Corcept Therapeutics | 17 | $455 |
| Lilly USA, LLC | 23 | $450 |
| Amgen | 21 | $441 |
| Insulet Corporation | 13 | $417 |
| Bayer | 18 | $397 |
| Sanofi-aventis U.S. LLC | 17 | $396 |
| IBSA Pharma Inc. | 8 | $274 |
| Amneal Pharmaceuticals LLC | 12 | $231 |
| Boehringer Ingelheim | 14 | $230 |
| Xeris Pharmaceuticals, Inc. | 10 | $206 |
| AbbVie | 8 | $141 |
| Mannkind Corporation | 2 | $134 |
| AstraZeneca(2 entities) | 7 | $126 |
| Radius Health, Inc. | 7 | $107 |
| Pfizer | 5 | $101 |
| Medtronic | 4 | $94 |
| Dexcom, Inc. | 3 | $85 |
| Merck | 5 | $82 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| GSK | 3 | $55 |
| Recordati_rare_diseases_inc. | 3 | $54 |
| Exact Sciences | 2 | $50 |
| Astellas Pharma US Inc | 2 | $36 |
| Tandem Diabetes Care, Inc. | 1 | $31 |
| Kyowa Kirin, Inc. | 2 | $29 |
| Novartis | 1 | $26 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $25 |
| Antares Pharma, Inc. | 1 | $20 |
| Halozyme Inc | 1 | $18 |
| Ascensia Diabetes Care US Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Amphastar Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CeQur Simplicity$629
- Tirosint$125
- AFREZZA$116
- Omnipod$106
How this compares
$7,491 in reported general payments places this provider in the 95th percentile of 487 nurse practitioner providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 248 | $465,773 |
| JardianceEmpagliflozin | 201 | $233,642 |
| TrulicityDulaglutide | 101 | $168,762 |
| MounjaroTirzepatide | 48 | $69,455 |
| FarxigaDapagliflozin Propanediol | 48 | $68,565 |
| JanuviaSitagliptin Phosphate | 55 | $66,646 |
| RybelsusSemaglutide | 27 | $54,516 |
| Tresiba Flextouch U-100Insulin Degludec | 55 | $43,767 |
| TradjentaLinagliptin | 27 | $32,226 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 112 | $16,731 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $15,822 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 17 | $15,745 |
| Novolog FlexpenInsulin Aspart | 41 | $13,472 |
| Humalog Kwikpen U-100Insulin Lispro | 42 | $12,335 |
| VascepaIcosapent Ethyl | 13 | $11,379 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $1,216 | $525,048288 claims |
| Boehringer IngelheimJardiance, Tradjenta | $230 | $265,867228 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $450 | $238,218149 claims |
| AstraZenecaFarxiga | $126 | $68,56548 claims |
| MerckJanuvia | $82 | $66,64655 claims |
| AbbVieSynthroid | $141 | $5,85681 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $231 | $5,178410 claims |
| Sanofi-aventis U.S. LLCLantus | $396 | $1,15812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 487 nurse practitioner providers in Delaware.
Other nurse practitioner in Newark
- Sedelle Henderson-BamideleNewark$13K
- Lyron DeputyNewark$6K
- Mark LandisNewark$5K
- Noreen Murphy BowensNewark$4K
- Mary ZimnyNewark$4K
- Amanda WardwellNewark$4K
- Heather DennisNewark$4K
- Anesha VictorNewark$3K
- Lori GrantNewark$3K
- Alexandra QuinnNewark$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.